Posted Date: 3/20/2017

SG Lab & Toxikon Europe Sign Partnership Agreement

Italian Stevanato Group, through its laboratory SG Lab, has signed a partnership agreement with Toxikon Europe, the Belgian Contract Research Organization (CRO) to include extractables and leachables analysis to its chemical-analytical testing services.

The collaboration is based on a mutual exchange of best-in-class knowledge, expertise and capabilities. SG Lab is specialized in analytical chemistry, material properties, physical, and mechanical performances to study the potential interactions between drugs and glass containers.

Over 35 years, Toxikon Europe has built a suite of world-class scientific services (extractables & leachables, toxicological assessments, impurity identifications, and biocompatibility testing) to support the pharmaceutical companies. This service is based upon a unique set of advanced analytical methodologies, using cutting-edge technologies and state-of-the-art instrumentation. In addition, Toxikon Europe developed a wide range of exclusive analytical and toxicological databases, which allow their staff to further optimize their methodologies and data interpretation.

The joint offer provides pharma companies with certification services able to address increasingly demanding global regulatory requirements. It also allows optimizing and customizing the glass container and its closure based on the study of the entire drug container’s life cycle.

“Thanks to this agreement, SG Lab can support pharmaceutical customers since the early stages of a new drug development. We help them in the selection of the best glass container including closure system, taking into account all the relevant aspects (compatibility, stability, quality),” saod Odra Pinato, SG Lab Analytics Coordinator. “Combining skilled glass experts with Toxikon’s experienced scientists and cutting-edge laboratory capabilities, we now can offer a comprehensive analytical service support.”

“By bundling forces with SG Lab, now we can leverage the collective expertise of SG Lab (glass testing, physical testing, and container/closure integrity testing) with our in-depth scientific knowledge and expertise in extractables and leachables testing (including subsequent toxicological assessments) and container/drug interaction evaluations. This unmatched technical and scientific combined support should allow pharmaceutical and biopharmaceutical companies moving much faster in the qualification and acceptance process of their selected container and closure systems. At the end, it is all about guaranteeing patient safety and well-being, and we hope we can make a substantial contribution to achieve this,” said Piet Christiaens, Toxikon Europe’s Scientific Director.

With a comprehensive expertise on research projects and science behind the primary packaging, SG Lab is the laboratory of Stevanato Group focused on analytical chemistry, material properties, physical, and mechanical performances. With a skilled team of experts having the best-in-class expertise in primary packaging, it can help the customer understand the potential interactions between the pharmaceutical products and the containers.

Some examples of SG Lab scientific activity are: delamination propensity investigation, surfaces, and silicone coating characterization (silicone layer coverage, thickness, and distribution), container performances and drug-container interaction.

Founded in 1949, Stevanato Group is committed to create systems, processes, and services that guarantee the integrity of parenteral medicines. It comprises two operational divisions dedicated to serve the pharmaceutical industry: Pharmaceutical Systems with Ompi specialized in glass primary packaging and Balda, focused on specialty plastics and delivery devices; Engineering Systems with Spami, Optrel, InnoScan and SVM, specialized in glass processing, inspection systems, assembly and packaging solutions. For more information, visit www.stevanatogroup.com.

Toxikon Europe is an independent, privately owned Contract Research Organization, specialized in providing premium Extractable & Leachable Services to the Pharmaceutical Industry. Based in Belgium, Toxikon Europe supports Pharma Companies - across the Globe - in developing worldwide compliant (FDA, EMA) Testing Strategies to qualify Container/Closure Applications and Pharmaceutical Production Equipment from an Extractable & Leachable Perspective. In addition, the Toxikon group also provides Biocompatibility Testing Services (In-Vivo and In-Vitro testing) to both the Medical Device and the Pharmaceutical Industries. Toxikon is ISO 17025 Accredited, GLP-Certified and GMP Accredited. Toxikon is also FDA registered. For more information, visit www.toxikon.be.

Related Taxonomy
Popularity:
This record has been viewed 1185 times.



Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions